Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation.
Vannucchi
A M
AM
Guidi
S
S
Guglielmelli
P
P
Glinz
S
S
Lombardini
L
L
Busca
A
A
Locatelli
F
F
Dall'Omo
A M
AM
Bosi
A
A
D015703:Antigens, CD / Q000235:genetics*; D000943:Antigens, Differentiation / Q000235:genetics*; D060908:CTLA-4 Antigen; D006086:Graft vs Host Disease / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000235:genetics*; D011110:Polymorphism, Genetic; D023001:Transplantation Tolerance; D016896:Treatment Outcome
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018950:Lipopolysaccharide Receptors